pharmaceuticals
Eli Lilly’s Breakthrough Obesity Drug Retatrutide Triumphs in First Late-Stage Diabetes Trial: What It Means for You
Eli Lilly is making waves with its new obesity drug, retatrutide. Recently, it passed a critical late-stage trial focusing on ... Read more
FDA’s New Move Against UniQure Sparks Controversy: What You Need to Know
During a recent media call organized by the FDA, a senior official spoke about UniQure and its experimental Huntington’s disease ... Read more
Trump’s Controversial Glyphosate Order Sparks MAHA Outrage—How This Could Empower Democrats
In recent news, the Make America Healthy Again (MAHA) movement faces unexpected challenges from the Trump administration. President Trump signed ... Read more
Inside Hims’ Earnings Call: CEO Tackles GLP-1 Compounding Concerns Head-On
In recent times, telehealth company Hims & Hers has sparked discussions about compounded GLP-1 weight loss medications. During a recent ... Read more
Novo Nordisk Shares Drop 15% as Weight Loss Drug Fails to Compete with Eli Lilly’s Breakthrough in Latest Trial
Novo Nordisk’s stock dropped by 15% on Monday after news that its weight-loss drug, CagriSema, did not meet its main ... Read more
New FDA Guidelines on Antibiotic Use in Farm Animals: A Double-Edged Sword in the Fight Against Antibiotic Resistance
In an effort to combat antibiotic resistance, the U.S. Food and Drug Administration (FDA) has released new guidelines for drug ... Read more
FDA Changes Its Stance: A New Review of Moderna’s Flu Vaccine is on the Horizon!
The FDA recently announced it will review Moderna’s application for a new flu vaccine, specifically for adults aged 50 and ... Read more
Insights from Moderna’s President: What the FDA’s Decision on the Flu Vaccine Means for You
In August, the FDA assured Moderna it would review its application for a new flu vaccine. This promise was based ... Read more
Sanofi CEO Paul Hudson Steps Down: What This Means for the Future of the Pharmaceutical Giant
Sanofi is making a big change at the top. The company announced that Paul Hudson will step down as CEO, ... Read more
FDA Chief Prasad Reverses Staff Decision: Moderna’s Flu Vaccine Application Denied
Vinay Prasad, a leading figure at the FDA, made a significant decision recently by rejecting Moderna’s request for a new ... Read more
